Class IIReported 2024-12-11

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-449-17

Recalled by ACCORD HEALTHCARE, INC.

Reason for Recall

Subpotent drug

Recall Number

D-0076-2025

Classification

Class II

Status

Ongoing

Category

drug

Initiated

2024-11-08

Reported

2024-12-11

Distribution

USA Nationwide

Code Info

Lot #: D2300191, Exp 12/31/2025

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.